Oncology · Good Syndrome

Living with Good Syndrome: Monitoring & Survivorship

At a Glance

Good syndrome requires long-term, individualized follow-up after thymoma surgery. Oncology watches for recurrence, immunology tracks immune function and immunoglobulin replacement, and lung testing plus infection prevention help limit bronchiectasis and lasting damage.

Living with Good syndrome means transitioning into a phase of careful, individualized “active surveillance.” Because the condition involves both a tumor and a persistent immune deficiency, your follow-up care must address two separate goals: monitoring for any return of the thymoma, and preventing the progressive lung damage that can occur from repeated infections ^[1]^[2].

The Two-Track Surveillance Schedule

Since your immune system usually does not recover after surgery, your medical calendar will involve regular check-ins with both oncology and immunology teams. The exact schedule is set by your treating doctors based on current guidelines, your tumor stage, and your clinical stability.

Oncology Follow-up (The Thymoma): Even after successful surgery, thymomas can return years later, most commonly in the lining of the lungs (the pleura) ^[3]^[4]. Doctors monitor this using imaging, such as chest CT scans ^[5]. The frequency of these scans is highly individualized—depending on your tumor’s stage, surgical margins, and histology (like B3) ^[6]^[7].
Immunology Follow-up (The Deficiency): You will need routine blood work to ensure your immunoglobulin replacement therapy is effective and to monitor your T-cell counts ^[8]^[9]. The timing of these labs is adjusted based on your infection history and overall health.

Protecting Your Long-Term Lung Health

A significant long-term risk in Good syndrome is bronchiectasis—a permanent scarring and widening of the airways caused by repeated bouts of pneumonia ^[10]^[11].

Monitoring your lung health involves:

Imaging: High-resolution CT scans can detect bronchiectasis, primarily by identifying persistently widened airways, thickened bronchial walls, and a lack of normal airway tapering ^[12]. Because of radiation exposure, scans are only done when clinically indicated.
Lung Function Tests: Regular spirometry or pulmonary function tests (PFTs) help your doctors track your breathing capacity and catch declines ^[13].
Prevention & Airway Clearance: If you develop bronchiectasis, you may use devices to help clear mucus from your lungs ^[14]. It is equally critical to avoid smoking, maintain good dental hygiene, get routine non-live vaccinations as approved by your immunologist, and manage your exposures during respiratory virus seasons.

Understanding Your Outlook

Your long-term health is closely tied to your specific tumor stage and your “infection burden”—how often you get sick and the severity of those illnesses ^[15]. Studies of historical cohorts have shown that severe infections involving the lungs, bloodstream, or central nervous system are strongly associated with poorer outcomes ^[15]^[16]. While a 10-year survival figure of 54% has been cited from small, older retrospective studies, it is crucial to understand that this is not an individual prognosis ^[15]^[11]. Your outlook depends on your specific tumor, your response to immunoglobulin, and your organ health.

The Psychological Aspect of Survivorship

Managing a rare, chronic condition like Good syndrome can be emotionally taxing. It is normal to experience “scan anxiety” before appointments or frustration with infusions ^[17].

Daily Management: Focus on consistency with your infusions. Never start a standby antibiotic without explicit instructions from your team.
Coordination: A “multidisciplinary” approach—where your oncologist, immunologist, and pulmonologist communicate closely—is the gold standard ^[18].
Vigilance: Continue to watch for red-flag symptoms, keeping a clinician-approved action plan on hand for immediate guidance.

Common questions in this guide

How often will I need chest scans after thymoma surgery with Good syndrome?

There is no single schedule for everyone. Your oncology team sets the timing of chest CT scans based on your thymoma stage, surgical margins, histology, and overall stability because thymomas can recur years after surgery, often in the pleura.

What blood tests are needed to monitor Good syndrome?

Immunology follow-up usually includes blood tests to assess whether immunoglobulin replacement is providing adequate support and to monitor T-cell counts. The timing is adjusted according to your infection history and general health.

How is bronchiectasis monitored in Good syndrome?

Repeated pneumonia can permanently widen and scar the airways, causing bronchiectasis. When clinically indicated, high-resolution chest CT can look for widened airways, thickened walls, and reduced tapering, while spirometry or other pulmonary function tests track breathing capacity.

What should I do if I develop a fever or new cough?

Ask your care team for a written action plan that explains when to call and when to seek emergency care, because infections can become serious with Good syndrome. Do not start a standby antibiotic unless your clinicians have specifically told you when and how to use it.

Which steps help protect my lungs and prevent infections with Good syndrome?

Avoid smoking, maintain good dental hygiene, follow your immunologist’s plan for routine non-live vaccinations, and manage respiratory exposures during virus seasons. If bronchiectasis develops, prescribed airway-clearance exercises or mucus-clearing devices may help remove mucus from the lungs.

What affects the long-term outlook with Good syndrome?

Long-term outlook depends on the thymoma stage, how well immunoglobulin replacement controls infections, infection burden, and the health of affected organs. Severe infections of the lungs, bloodstream, or central nervous system are linked with poorer outcomes, but older survival statistics from small studies cannot predict one person’s prognosis.

How can I manage scan anxiety and the emotional strain of Good syndrome?

Scan anxiety and frustration with ongoing infusions are understandable challenges of living with a chronic condition. Tell your care team if monitoring is taking an emotional toll and ask about mental-health or peer support, while coordinated oncology, immunology, and pulmonary care can make follow-up easier.

Curated prompts to bring to your next appointment.

1.What is my individualized schedule for oncology scans, given the stage and histology of my thymoma?
2.Can you help me coordinate my schedule so that my oncology visits and my immunology labs happen smoothly?
3.Based on my latest chest CT, do I have signs of airway widening (bronchiectasis), and should I be seeing a pulmonologist?
4.What is my specific 'action plan' for a fever or a new cough—when should I call, and when do I go to the ER?
5.What precautions should I take regarding dental care, travel, or respiratory exposures during flu season?

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

Key takeaways

Good syndrome follow-up uses two tracks: oncology monitors for thymoma recurrence, while immunology monitors the persistent immune deficiency.
Chest CT schedules are individualized according to tumor stage, surgical margins, histology, and clinical stability because thymomas can recur years later.
Repeated respiratory infections can cause bronchiectasis, so clinically indicated chest imaging and spirometry or other pulmonary function tests help monitor lung health.
Immunoglobulin replacement, approved non-live vaccinations, airway-clearance techniques, smoking avoidance, dental hygiene, and exposure management support infection and lung health.
The long-term outlook depends on tumor stage, infection burden, treatment response, and organ health; older survival statistics do not predict an individual prognosis.

References (18)

1
Unraveling the Natural History of Good's Syndrome: A Progressive Adult Combined Immunodeficiency.
Kabir A, Polito V, Tsoukas CM
The journal of allergy and clinical immunology. In practice 2024; (12(3)):744-752.e3 doi:10.1016/j.jaip.2023.12.018.
PMID: 38122866
2
Clinical Characteristics, Surgical Risks, and Long-Term Prognosis of Good's Syndrome.
Otsuka S, Shiiya H, Sasaki A, et al.
Cureus 2026; (18(6)):e111036 doi:10.7759/cureus.111036.
PMID: 42491992
3
Long-term outcomes of 307 patients after complete thymoma resection.
Yuan ZY, Gao SG, Mu JW, et al.
Chinese journal of cancer 2017; (36(1)):46 doi:10.1186/s40880-017-0213-8.
PMID: 28506287
4
Surgical treatment of recurrent thymoma: is it worthwhile?†.
Marulli G, Margaritora S, Lucchi M, et al.
European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 2016; (49(1)):327-32 doi:10.1093/ejcts/ezv086.
PMID: 25755187
5
State of the Art: MR Imaging of Thymoma.
Carter BW, Benveniste MF, Truong MT, Marom EM
Magnetic resonance imaging clinics of North America 2015; (23(2)):165-77.
PMID: 25952513
6
Impact of postoperative surveillance via computed tomography after radical resection for thymoma.
Maru N, Hino H, Utsumi T, et al.
Mediastinum (Hong Kong, China) 2025; (9()):31 doi:10.21037/med-25-41.
PMID: 41503576
7
Surgical treatment of single and multiple thymoma recurrences.
Carretta A, Ciriaco P, Muriana P, et al.
General thoracic and cardiovascular surgery 2020; (68(4)):350-356 doi:10.1007/s11748-019-01229-w.
PMID: 31637673
8
Features and outcomes of immunoglobulin therapy in patients with Good syndrome at Thailand's largest tertiary referral hospital.
Thongngarm T, Boonyasiri A, Pradubpongsa P, et al.
Asian Pacific journal of allergy and immunology 2019; (37(2)):109-115 doi:10.12932/AP-131117-0196.
PMID: 29888926
9
In-depth blood immune profiling of Good syndrome patients.
Torres-Valle A, Aragon L, Silva SL, et al.
Frontiers in immunology 2023; (14()):1285088 doi:10.3389/fimmu.2023.1285088.
PMID: 38035080
10
Good syndrome combined with multiple microbial pulmonary infections: case report and review of the literature.
Ye Y, Wang J, Bao B, et al.
Immunologic research 2024; (72(6)):1288-1298 doi:10.1007/s12026-024-09528-y.
PMID: 39180607
11
Clinical and laboratory features of seventy-eight UK patients with Good's syndrome (thymoma and hypogammaglobulinaemia).
Zaman M, Huissoon A, Buckland M, et al.
Clinical and experimental immunology 2019; (195(1)):132-138 doi:10.1111/cei.13216.
PMID: 30216434
12
Imaging Features of Primary Immunodeficiency Disorders.
Rodriguez JA, Bang TJ, Restrepo CS, et al.
Radiology. Cardiothoracic imaging 2021; (3(2)):e200418 doi:10.1148/ryct.2021200418.
PMID: 33969305
13
The relation between inspiratory muscle strength and bacterial colonization and other clinical factors in patients with non-cystic fibrosis bronchiectasis.
Candemir İ, Ergün P, Demir N, Taşdemir F
Tuberkuloz ve toraks 2023; (71(2)):113-122 doi:10.5578/tt.20239914.
PMID: 37345393
14
Granulomatous-lymphocytic interstitial lung disease and recurrent sinopulmonary infections in a patient with Good's syndrome.
Jensen ML, Bendstrup E, Hilberg O
BMJ case reports 2015; (2015()).
PMID: 26424818
15
When the Good Syndrome Goes Bad: A Systematic Literature Review.
Shi Y, Wang C
Frontiers in immunology 2021; (12()):679556 doi:10.3389/fimmu.2021.679556.
PMID: 34113351
16
Good's syndrome and infections in a large retrospective cohort of thymoma.
Jia W, Jin L, Huan X, et al.
Frontiers in immunology 2026; (17()):1733466 doi:10.3389/fimmu.2026.1733466.
PMID: 42292484
17
PROMIS-29 survey confirms major impact of fatigue on health-related quality of life in common variable immunodeficiency.
Zhang S, Kline M, Fuleihan RL, et al.
Immunologic research 2020; (68(6)):379-388 doi:10.1007/s12026-020-09162-4.
PMID: 33161558
18
Immunodeficiency and thymoma in Good syndrome: Two sides of the same coin.
Guevara-Hoyer K, Fuentes-Antrás J, Calatayud Gastardi J, Sánchez-Ramón S
Immunology letters 2021; (231()):11-17 doi:10.1016/j.imlet.2020.12.010.
PMID: 33418010

This page is for informational purposes only and does not constitute medical advice. Your oncology, immunology, and pulmonary teams should personalize your surveillance, infection action plan, and treatment.

Get notified when new evidence is published on Thymoma-hypogammaglobulinemia syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Guide Contents